Quantum Biopharma QNTM
NASDAQ QNTM
$3.60 -0.22 (-5.76%)
At close: Sep 30, 2026 · 4:00 PM EDT

Quantum Biopharma (QNTM) Convertible Debt (2024 - 2026)

Updated

Quantum Biopharma (QNTM) recorded Convertible Debt of $597,843 in Q2 2026, up 264.4% from $164,075 a year earlier and up 23.1% from the prior quarter.

Analysis

Quantum Biopharma (QNTM) Convertible Debt (2024 - 2026) Analysis & Trends

At the end of FY2025, Quantum Biopharma reported Convertible Debt of $472,497, up 210.6% from FY2024.

  • Across earlier years, Convertible Debt came in at $152,113 in FY2024.
  • On a year-over-year basis, Convertible Debt has increased for three consecutive quarters.
  • Per Business Quant, the preceding three quarters came in at $485,517 (Q1 2026), $472,497 (Q4 2025) and $429,995 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Quantum Biopharma 14.85 Mn 2.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 597,843.00
Mar 31, 2026 485,517.00
Dec 31, 2025 472,497.00
Sep 30, 2025 429,995.00
Jun 30, 2025 164,075.00
Mar 31, 2025 156,920.00
Dec 31, 2024 152,113.00
API Access

Quantum Biopharma Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=QNTM&period=max&api_key=YOUR_API_KEY